Latest News
Conference Coverage
MedPAC mulls boost to payments for E&M visits
WASHINGTON – The commissioners debated whether the pay boost would make a difference.
From the Journals
AHA: Heart health helps optimize breast cancer outcomes
Cardiovascular health should be monitored at every step, from breast cancer diagnosis to after treatment.
Conference Coverage
Spray-dried plasma inches toward clinical trials
In vitro studies show strong results for spray-dried plasma, which could have implications on the battlefield.
From the Journals
CAR T cells produce longest survival in low disease burden ALL patients
The phase 1 trial examines 19-28z CD19 CAR T cells manufactured at Memorial Sloan Kettering Cancer Center.
From the Journals
Tisagenlecleucel looks effective in phase 2 study of young ALL patients
Tisagenlecleucel had transitory but high-grade toxicity in this population of children and young adults.
From the Journals
Real-world study makes case for continuous treatment in multiple myeloma
The study evaluated more than 600 adults with newly diagnosed multiple myeloma who relapsed.
Feature
Expert advice for the corporate titans taking on health care
Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. want to disrupt health care.
Latest News
Health care gets little attention in State of the Union address
It’s anyone’s guess as to how Mr. Trump might lower drug costs.
From the Journals
Background color a dermoscopic clue to cutaneous B-cell lymphoma
On dermoscopy, almost 80% of the lesions showed salmon- or yellow- to orange-colored background areas.
Conference Coverage
Controversy surrounds calf vein thrombosis treatment
CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.
Conference Coverage
LAA occlusion boosts anticoagulants’ protection
ORLANDO – When atrial fibrillation patients have cardioembolic events despite anticoagulation, left atrial appendage occlusion can augment their...